UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

PLoS pathogens, 2007-10, Vol.3 (10), p.1422-1431

2007

Volltextzugriff (PDF)

Human Capillary Morphogenesis Protein 2 Functions as an Anthrax Toxin Receptor

Proceedings of the National Academy of Sciences - PNAS, 2003-04, Vol.100 (9), p.5170-5174

2003

Volltextzugriff (PDF)

Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation

PloS one, 2007-03, Vol.2 (3), p.e329

2007

Volltextzugriff (PDF)

Anthrax toxin receptor 2-dependent lethal toxin killing in vivo

PLoS pathogens, 2006-10, Vol.2 (10), p.e111

2006

Volltextzugriff (PDF)

Evolution of Broad Host Range in Retroviruses Leads to Cell Death Mediated by Highly Cytopathic Variants

Journal of Virology, 2006-01, Vol.80 (2), p.562-570

2006

Volltextzugriff (PDF)

Receptor-Specific Requirements for Anthrax Toxin Delivery into Cells

Proceedings of the National Academy of Sciences - PNAS, 2005-09, Vol.102 (37), p.13278-13283

2005

Volltextzugriff (PDF)

Antitoxins: novel strategies to target agents of bioterrorism

Nature reviews. Microbiology, 2004-09, Vol.2 (9), p.721-726

2004

Volltextzugriff (PDF)

Whole-cell Voltage Clamp Measurements of Anthrax Toxin Pore Current

The Journal of biological chemistry, 2005-11, Vol.280 (47), p.39417-39422

2005

Volltextzugriff (PDF)

Mechanisms of Avian Retroviral Host Range Extension

Journal of Virology, 2003-06, Vol.77 (12), p.6709-6719

2003

Volltextzugriff (PDF)

Correction: Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In Vivo

PLoS pathogens, 2008-10, Vol.4 (10)

2008

Volltextzugriff (PDF)

A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells

The Journal of biological chemistry, 2018-01, Vol.293 (3), p.941-952

2018

Volltextzugriff (PDF)

Structure and biophysical characterization of the human full-length neurturin–GFRa2 complex: A role for heparan sulfate in signaling

The Journal of biological chemistry, 2018-04, Vol.293 (15), p.5492-5508

2018

Volltextzugriff (PDF)

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

Blood, 2011-04, Vol.117 (17), p.4542-4551

2011

Volltextzugriff (PDF)

An antidote approach to reduce risk and broaden utility of antibody-based therapeutics

The Journal of biological chemistry, 2017-05, Vol.292 (20), p.8498-8506

2017

Volltextzugriff (PDF)

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody

The Journal of biological chemistry, 2017-03, Vol.292 (10), p.4361-4370

2017

Volltextzugriff (PDF)

An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection

Journal of virology, 2015-04, Vol.89 (8), p.4549-4561

2015

Volltextzugriff (PDF)

A mammalian expression system for high throughput antibody screening

Journal of immunological methods, 2013-09, Vol.395 (1-2), p.45-53

2013

Volltextzugriff (PDF)

Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface

The Journal of biological chemistry, 2017-09, Vol.292 (35), p.14401-14412

2017

Volltextzugriff (PDF)

Abstract LB-002: A fully human antibody binds Tn and sTn carbohydrate antigens specifically on serine residues, without need for polypeptide interaction

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-002-LB-002

2018

Volltextzugriff (PDF)

Abstract B104: A therapeutic antibody candidate against the broadly expressed Tn and STn carbohydrate cancer antigens

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.B104-B104

2018

Volltextzugriff (PDF)

Abstract A062: Using CA19-9 as a translational biomarker for sLea targeted agents MVT-5873 and MVT-1075 in cancer

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.A062-A062

2018

Volltextzugriff (PDF)

Binding of Anthrax Toxin to Its Receptor Is Similar to α Integrin-Ligand Interactions

The Journal of biological chemistry, 2003-12, Vol.278 (49), p.49342-49347

2003

Volltextzugriff (PDF)

Substrate Sequence Selection by Retroviral Integrase

Journal of Virology, 2001-02, Vol.75 (3), p.1359-1370

2001

Volltextzugriff (PDF)

Chromosomal and Extrachromosomal Instability of the cyclin D2 Gene is Induced by Myc Overexpression

Neoplasia (New York, N.Y.), 1999-08, Vol.1 (3), p.241-252

1999

Volltextzugriff (PDF)

Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6–independent phenotype by murine plasmacytomas and hybridomas

Blood, 2000-11, Vol.96 (10), p.3514-3521

2000

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

Human Capillary Morphogenesis Protein 2 Functions as an Anthrax Toxin Receptor

Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation

Anthrax toxin receptor 2-dependent lethal toxin killing in vivo

Evolution of Broad Host Range in Retroviruses Leads to Cell Death Mediated by Highly Cytopathic Variants

Receptor-Specific Requirements for Anthrax Toxin Delivery into Cells

Antitoxins: novel strategies to target agents of bioterrorism

Whole-cell Voltage Clamp Measurements of Anthrax Toxin Pore Current

Mechanisms of Avian Retroviral Host Range Extension

Correction: Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In Vivo

A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells

Structure and biophysical characterization of the human full-length neurturin–GFRa2 complex: A role for heparan sulfate in signaling

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

An antidote approach to reduce risk and broaden utility of antibody-based therapeutics

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody

An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection

A mammalian expression system for high throughput antibody screening

Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface

Abstract LB-002: A fully human antibody binds Tn and sTn carbohydrate antigens specifically on serine residues, without need for polypeptide interaction

Abstract B104: A therapeutic antibody candidate against the broadly expressed Tn and STn carbohydrate cancer antigens

Abstract A062: Using CA19-9 as a translational biomarker for sLea targeted agents MVT-5873 and MVT-1075 in cancer

Binding of Anthrax Toxin to Its Receptor Is Similar to α Integrin-Ligand Interactions

Substrate Sequence Selection by Retroviral Integrase

Chromosomal and Extrachromosomal Instability of the cyclin D2 Gene is Induced by Myc Overexpression

Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6–independent phenotype by murine plasmacytomas and hybridomas

Suchergebnisse filtern